| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |